A parallel-group treatment, proof-of-concept Phase 2, multicenter, double blind, randomized two arm clinical trial to investigat

A parallel-group treatment, proof-of-concept Phase 2, multicenter, double blind, randomized two arm clinical trial to investigate the efficacy and safety of subcutaneous NT 201 injections compared with placebo injections in decreasing pain intensity in male and female participants aged 18 years and older with moderate to severe chronic peripheral neuropathic pain due to postherpetic neuralgia or peripheral nerve injury.

Obert

Codi protocol: M602011079
Codi EudraCT: No aplica
Grup de recerca: Farmacologia Clínica
Servei: Anestèsia
Investigador/a principal: Medel Rebollo, Francisco Javier
Malaltia: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase II